MIRA INFORM REPORT

 

 

Report Date :

19.06.2014

 

IDENTIFICATION DETAILS

 

Name :

LAURUS LABS PRIVATE LIMITED (w.e.f. 21.02.2012)

 

 

Formerly Known As :

APTUIT LAURUS PRIVATE LIMITED

 

 

Registered Office :

2nd Floor, Serene Chambers, Road No 7, Banjara Hills, Hyderabad, Andhra Pradesh – 500034

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

19.09.2005

 

 

Com. Reg. No.:

01-047518

 

 

Capital Investment / Paid-up Capital :

Rs.777.010 Millions

 

 

CIN No.:

[Company Identification No.]

U24239AP2005PTC047518

 

 

PAN No.:

[Permanent Account No.]

AABCL1170C

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturers of specially nutraceutical ingredients that can be integrated into dietary supplements, nutritional products and functional products

 

 

No. of Employees :

1500 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (51)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 10000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established company having a fine track record.

 

The management has seen significant improvement in the financial performance, characterised by robust growth in revenues and improvement in profitability margin during 2013.

 

Liquidity position of the company appears to be sound.

 

The rating also take into consideration the regulatory approvals which are been successfully sanctioned by various countries for establishing its facilities.

 

Trade relations are fair. Business is active. Payment terms are reported as regular and as per commitments.

 

In view of experienced promoters and various strategic partnerships with reputed organisation, the subject can be considered good for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

The economy grew 4.7 %in 2013/14, marking a second straight year of sub-5 % growth – the worst slowdown in more than a quarter of a century. The data was below an official estimate of 4.9 % annual growth and compared with 4.5 % in the last fiscal year. However, the current account deficit narrowed sharply to $ 32.4 billion at 1.7 % of gross domestic product, in 2013/14 from a record high of $ 98.8 billion or 4.7 %, the year before.A sharp fall in gold imports due to restrictions on overseas purchases and muted import of capital goods helped shrink the current account deficit.

 

Online retailer Flipkart has acquired fashion portal Myntra as it prepares to battle with the rapidly expanding India arm of the global e-commerce giant Amazon. The company raised $ 210 million from Russian Investment firm DST Global which has also invested in companies like Facebook, Twitter and Alibaba Group.

 

General Motors will start exporting vehicles from its Talegaon plant near Pune in the second half of 2014. GM was one of the few global carmakers that was using its India plant only for the domestic market.

 

Google has overtaken Apple as the world’s top brand in terms of value, according to global market research agency Millward Brown. Google’s brand value shot up 40 % in a year to $ 158.84 billion. The top 10 of the 100 slots were dominated by US companies.

 

Infosys lost another heavy weight when B G Srinivas, a board member put in his papers. He is the third CEO-hopeful to quit after Chairman N R Narayana Murthy’s return to the company – Ashok Vemuri and V Balakrishnan being the other two.While Vemuri went on to lead IGate, Balakrishnan joined politics.

 

Naresh Goyal – promoted Jet Airways posted biggest quarterly loss – Rs 2153.37 crore – in the three months ended March 31, mainly because it has been offering discounts to passengers to fill planes.

 

William S Pinckney – Chairman and CEO of Amway India was arrested by the Andhra Pradesh Police in connection with a complaint against the direct selling firm. This is the second time that he has been taken into custody. A year, ago the Kerala Police had arrested Pinckney and two company directors on charges of financial irregularities.

 

China has told its state-owned enterprises to sever links with American consulting firms after the United States charged five Chinese military officers wih hacking US companies. China’s action which targets consultancies like McKinsey & Co. and the Boston Consulting Group, sterns from fears that the first are providing trade secrets to the US governments.

 

India has emerged as a country with some of the highest unregistered businesses in the world. Indonesia has the maximum number of shadow businesses, says a study of 68 countries by Imperial College Business School in London.

 

Pfizer has abandoned its attempt to buy AstraZeneca for nearly $ 118 billion after the latter refused an offer of 55 pounds a share.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long term bank facilities: A-

Rating Explanation

Adequate degree of safety and low credit risk.

Date

10.07.2013

 

Rating Agency Name

CARE

Rating

Short term bank facilities: A2+

Rating Explanation

Strong degree of safety and low credit risk.

Date

10.07.2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION PARTED BY

 

Name :

Mr. Narasimma Reddy

Designation :

General Manager

Contact No.:

91-40-23420500

Date :

16.06.2014

 

 

LOCATIONS

 

Registered / Corporate Office :

2nd Floor, Serene Chambers, Road No 7, Banjara Hills, Hyderabad, Andhra Pradesh – 500034, India

Tel. No.:

91-40-39804333 / 23420500/501

Fax No.:

91-40-39804320

E-Mail :

nagaraj.a@aptuitlaurus.com

info@aptuitlaurus.com

Website :

www.aptuitlaurus.com

Location:

Owned

 

 

Research and Development  Office :

Plot No: DS1, ICICI Knowledge Park, Turkapally, Shameerpet Mandal, Hyderabad – 500 034, India

Tel. No.:

91-40-23480480

Fax No.:

91-40-23480481

 

 

Drug Substance Facility :

Plot No. 21, Jawaharlal Nehru Pharma City, Parawada, Visakhapatnam – 531021, India

Tel. No.:

91-8913061222

Fax No.:

91-8913061270

 

 

Aptuit Informatics:

Plot No. 100-101, Export Promotion Park, Whitefield, Bangalore – 560 066, India

Tel. No.:

91-80-41907800

Fax No.:

91-80-41907805

 

 

DIRECTORS

 

As on 13.06.2013

 

Name :

Dr. Chava Satyanarayana

Designation :

Whole Time Director and Chief Executive Officer

Address :

H.No.8 – 2 – 293/82/A/303, Plot No. 303, Road No. 25, Jubilee Hillis, Hyderabad – 500 033, Andhra Pradesh, India

Date of Birth/Age :

10.03.1961

Qualification :

M.Sc ; Ph.D

Date of Appointment :

21.01.2006

DIN No.:

00211921

PN No.:

ABWPC2407Q

 

 

Name :

Dr. Sri Hari Raju Kalidindi

Designation :

Executive Director

Address :

Villa No. 3, Aparna Orchids, Izzatnagar, Kondapur, Hyderabad – 500 084, Andhra Pradesh, India

Date of Birth/Age :

01.07.1963

Qualification :

M.Sc ; Ph.D

Date of Appointment :

24.04.2006

DIN No.:

00982034

PAN No.:

ASTPK1009N

 

 

Name :

Mr. Venkata Ravi Kumar Vantaram

Designation :

Executive Director

Address :

No. 8, Sai Ansh Arcade, Durga Vihar Colony, Tirumalgherry, Hyderabad – 500 015, Andhra Pradesh, India

Date of Birth/Age :

01.07.1965

Qualification :

M.Com; AICWA

Date of Appointment :

30.11.2006

PAN No.:

ACFPV4907L

DIN No.:

01424180

 

 

Name :

Mr. Rajesh Kumar Dugar

Designation :

Director

Address :

31, Chitrakoot, Altamount Road, Mumbai – 400026, Maharashtra, India

Date of Birth/Age :

01.07.1969

Date of Appointment :

14.02.2012

DIN No. :

00307729

 

 

Name :

Dr. Robert Mark Weisskoff

Designation :

Director

Address :

18, Preston Road, Lexington Massachusetts – 024203227

Date of Birth/Age :

22.06.1962

Date of Appointment :

14.02.2012

DIN No. :

05122018

 

 

Name :

Mr. Brian Thomas Regan

Designation :

Director

Address :

115, Bay Berry Road, New Canaan Connecticut 06840

Date of Birth/Age :

29.11.1977

Date of Appointment :

14.02.2012

DIN No. :

05205905

 

 

Name :

Mr. Francis Jackson Wright

Designation :

Director

Address :

10 Greenwich Terrace, 104 Ritch Avenue West, Greenwich CT - 06831

Date of Birth/Age :

24.01.1948

Date of Appointment :

14.02.2012

DIN No. :

01609467

 

 

Name :

Mr. Amal Ganguli

Designation :

Director

Address :

J-6/7, DLF, Phase – II, Gurgaon, Haryana – 122002, India

Date of Birth/Age :

17.10.1939

Date of Appointment :

30.08.2007

DIN No. :

00013808

 

 

KEY EXECUTIVES

 

Name :

Mr. Nagaraj Kumar Annabattula

Designation :

Company Secretary

Address :

5-22, Sai Vihar Nagar, Phase – I, Meerpet, Ranga Reddy District – 079, India

Date of Birth/Age :

05.05.1975

Date of Appointment :

16.06.2007

PAN No.:

AEJPA0477L

 

 

Name :

Mr. Narasimma Reddy

Designation :

General Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 13.06.2013

 

SHAREHOLDING DETAIL FILE ATTACHED

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 13.06.2013

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

46.30

Bodies corporate

1.31

Directors or relatives of Directors

41.30

Other top fifty shareholders

11.09

Total

100.00

 

 


 

BUSINESS DETAILS

 

Line of Business :

Manufacturers of specially nutraceutical ingredients that can be integrated into dietary supplements, nutritional products and functional products.

 

 

Products :

ITC code No.

product or service

30068000

Active Pharmaceutical Ingredients (API) and Intermediates Contract Research Services

 

 

Exports :

 

Countries :

  • South Africa
  • Europe

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

L/C, Cash and Credit

 

 

Purchasing :

L/C, Cash and Credit

 

 

GENERAL INFORMATION

 

Customer:

Retailers

 

 

No. of Employees :

1500 (Approximately)

 

 

Bankers :

  • ICICI Bank Limited, Landmarkrace Cource Circle, Alkapuri, Baroda - 390015, Gujarat, India
  • ING Vysya Bank Limited, 1-7-1,T.Subbarami Reddy Complex, Sardar Patel Road,, Secunderabad - 500003, Andhra Pradesh, India
  • Bank Of Bahrain and Kuwait B.S.C., 6-3-550, L.B. Bhawan, Akashganga, Somajiguda, Hyderabad - 500082, Andhra Pradesh, India
  • Punjab National Bank, 4-1-427, Agm's Office, Bank Street, Hyderabad - 500001, Andhra Pradesh, India
  • State Bank of Hyderabad, Industrial Finance Branch, Topaz Building, Amrutha Hills, Punjagutta, Hyderabad - 500082, Andhra Pradesh, India
  • State Bank of India, Overseas Branch, 2nd Floor, Rajala Centre, Road No.36, Jubilee Hill, Hyderabad - 500033, Andhra Pradesh, India

 

 

Facilities :

Secured Loan

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

Long-term Borrowings

 

 

Rupee term loans from banks

412.660

345.300

Foreign currency term loans from banks

256.990

0.000

Term loans from others

0.000

12.330

Other loans and advances

17.380

0.000

Other loans and advances

0.000

5.740

Short-term borrowings

 

 

Working capital loans from banks

1269.210

782.140

Loans repayable on demand

509.210

187.400

Term loans from banks

0.000

320.340

Total

2465.450

1653.250

 

 

 

Banking Relations :

--

 

 

Financial Institute:

Tata Capital Limited, One Forbes, Dr V B Gandhi Marg, Fort, Mumbai - 400001,

Maharashtra, India

 

 

Auditors :

 

Name :

S.R. Batliboi Associates

Chartered Accountant

Address :

Plot No 18, Oval Office, Ilabs Centre Software Units, Layout Hitee City, Madhapur, Hyderabad – 500081, India

Tel No. :

91-40-66274202

PAN N Income-tax PAN of auditor or auditor's firm :

AABFS3421N

 

 

Company which exercises significant influence:

  • FIL Capital Management(Mauritius) Limited #
  • FIL Capital Advisor Trustee Company Private Limited #
  • Aptuit Kansas City LLC ##
  • Aptuit Edinburgh Ltd ##
  • Aptuit (Deeside) Limited ##
  • Aptuit (Glasgow) Limited ##
  • Aptuit Oxford Limited ##

 

Note:

 

  • # effective from February 14, 2012
  • ## Ceased from February 14, 2012

 

 

CAPITAL STRUCTURE

 

As on: 13.06.2013

 

Authorised Capital: Rs.880.000 Millions

 

Issued, Subscribed & Paid-up Capital: Rs.778.393 Millions

 

As on 31.03.2013

 

Authorised Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

20899496

Equity Shares

Rs.10/- each

Rs.208.995 Millions

6900000

Preference Shares

Rs.10/- each

Rs.69.000 Millions

2477387

Preference Shares

Rs.243/- each

Rs. 602.005 Millions

 

 

 

 

 

Total

 

Rs.880.000 Millions

 

Issued, Subscribed & Paid-up Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

15240630

Equity Shares

Rs.10/- each

Rs.152.406 Millions

2259060

Preference Shares

Rs.10/- each

Rs. 22.590 Millions

2477387

Preference Shares

Rs.243/- each

Rs. 602.005 Millions

 

 

 

 

 

Total

 

Rs.777.001 Millions

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

777.010

777.010

173.000

(b) Reserves & Surplus

1815.980

914.850

699.250

(c) Money received against share warrants

0.000

0.000

0.010

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

2592.990

1691.860

872.260

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

687.030

363.370

904.530

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

41.810

10.860

(d) long-term provisions

28.010

17.730

0.000

Total Non-current Liabilities (3)

715.040

422.910

915.390

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

1778.420

1289.880

976.280

(b) Trade payables

1322.410

970.850

883.490

(c) Other current liabilities

569.010

716.250

541.140

(d) Short-term provisions

57.060

59.750

16.870

Total Current Liabilities (4)

3726.900

3036.730

2417.780

 

 

 

 

TOTAL

7034.930

5151.500

4205.430

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

2342.640

1862.530

1888.230

(ii) Intangible Assets

12.890

2.870

1.730

(iii) Capital work-in-progress

727.810

321.150

10.970

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

118.200

97.000

97.000

(d)  Long-term Loan and Advances

328.500

92.360

26.290

(e) Other Non-current assets

196.240

77.950

94.220

Total Non-Current Assets

3726.280

2453.860

2118.440

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

1561.900

986.320

756.230

(c) Trade receivables

1566.960

1483.140

1255.440

(d) Cash and cash equivalents

26.690

92.440

4.100

(e) Short-term loans and advances

124.180

83.290

70.890

(f) Other current assets

28.920

52.450

0.330

Total Current Assets

3308.650

2697.640

2086.990

 

 

 

 

TOTAL

7034.930

5151.500

4205.430

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

7185.000

4507.000

2819.550

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

1499.000

795.000

484.920

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

412.000

396.000

253.940

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

1087.000

399.000

230.980

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

226.000

183.000

172.080

 

 

 

 

 

 

PROFIT BEFORE TAX

861.000

216.000

58.900

 

 

 

 

 

Less

TAX                                                                 

(21.000)

0.000

(35.000)

 

 

 

 

 

 

PROFIT AFTER TAX                

882.000

216.000

93.900

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

 

 

 

Basic

57.88

19.45

9.02

 

Diluted

43.41

9.64

4.22

 

Particulars

 

 

 

31.03.2014

Sales Turnover (Approximately)

 

 

11560.000

 

The above information has been parted by Mr. Narasimma Reddy (General Manager)

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

11.98
4.79

2.09

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

33.20
4.56

1.44

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.33
0.13

0.07

 

 

 
 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.95
0.98

2.15

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

0.89
0.88

2.39

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

173.000

777.010

777.010

Reserves & Surplus

699.250

914.850

1815.980

Net worth

872.250

1691.860

2592.990

 

 

 

 

long-term borrowings

904.530

363.370

687.030

Short term borrowings

976.280

1289.880

1778.420

Total borrowings

1880.810

1653.250

2465.450

Debt/Equity ratio

2.156

0.977

0.951

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

2819.550

4507.000

7185.000

 

 

59.848

59.419

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

2819.550

4507.000

7185.000

Profit

93.900

216.000

882.000

 

3.33%

4.79%

12.28%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last four years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

BUSINESS OPERATIONS

 

During the year the Company achieved:

 

Growth of 59% revenue, 89% EBITDA and 299% PBT over previous year Scrip award - Best Company in an Emerging Market Pharmexcil award for Outstanding Exports Performance FAPCCI award for Excellence in export performance Development of 7 new generic APIs totaling to 40 commercialised APIs Manufacture of 3 clinical phase APIs Development 2 nutraceutical products Filing of 8 drug master files totaling to 23 products Filing of 16 patents totaling to 68 patents US FDA, WHO, EDQM approvals for Visakhapatnam drug substance facility Investment of Rs.1,100 Mn for creation and expansion of production suites.

 

OUTLOOK

 

Business prospects remain positive because of the growing global demand for generics and opportunities provided by patents expiring in developed markets. The business proportions and synergies forms part of growth prospects which are discussed in detail in the Management’s Discussion and Analysis (MDA), which forms part of this Annual Report.

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10468024

16/12/2013

490,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE
COMPLEX, CUFFE PARADE, MAHARASHTRA - 400005, INDIA

B92662568

2

10449850

06/09/2013

225,300,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, GUJARAT - 390015, INDIA

B85312635

3

10441811

15/07/2013

250,000,000.00

CITIBANK N. A.

1ST FLOOR, QUEENS PLAZA, SARDAR PATEL ROAD, HYD
ERABAD, ANDHRA PRADESH - 500003, INDIA

B81301582

4

10406036

03/08/2013 *

1,000,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE
COMPLEX, CUFFE PARADE, MAHARASHTRA - 400005, INDIA

B83339739

5

10373290

03/08/2013 *

650,000,000.00

ING VYSYA BANK LIMITED

22,GROUND FLOOR, ING VYSYA HOUSE, M.G.ROAD, BANGALORE, KARNATAKA - 560001, INDIA

B82948688

6

10369823

03/08/2013 *

297,000,000.00

BANK OF BAHRAIN AND KUWAIT B.S.C.

43, GOVERNMENT AVENUE, P O BOX 597,, MANAMA, - 597, BAHRAIN

B83337220

7

10316958

03/08/2013 *

250,000,000.00

BANK OF BAHRAIN AND KUWAIT B.S.C.

6-3-550, L.B. BHAWAN, AKASHGANGA, SOMAJIGUDA, HYDERABAD, ANDHRA PRADESH - 500082, INDIA

B83356568

8

10313484

03/08/2013 *

370,000,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, BARODA, GUJARAT - 390015, INDIA

B83301499

9

10292162

23/06/2011

155,280,000.00

BANK OF BAHRAIN AND KUWAIT B.S.C.

6-3-550, L.B.BHAWAN, AKASHGANGA, SOMAJIGUDA, HYDERABAD, ANDHRA PRADESH - 500082, INDIA

B14980593

10

10213560

03/08/2013 *

200,000,000.00

PUNJAB NATIONAL BANK

4-1-427, AGM'S OFFICE, BANK STREET, HYDERABAD, ANDHRA PRADESH - 500001, INDIA

B83289488

 

* Date of charge modification

 

CONTINGENT LIABILITIES:

 

(Rs. in millions)

PARTICULARS

31.03.2013

Outstanding bank guarantees (excluding performance obligations)

 

Bills Discounted

886.330

Demad for direct taxes under appeal #

10.100

Demad for indirect taxes under appeal #

1.650

Preference Dividend

0.010

Note:

 

* Amount less than Indian Rupees 10,000

 

# Based on favourable decisions in similar cases, legal opinion taken by the Company, discussions with the solicitors, etc., the Company believes that there is a fair chance of decisions in its favour with respect to all the items listed above and hence no provision has been considered necessary in these respects.

 

FIXED ASSETS

 

Tangible assets

 

  • Land
  • Buildings
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Computer equipments

 

Intangible assets

 

  • Computer software

 

PRESS RELEASES

 

TOP PES IN RACE FOR LAURUS LABS STAKE

11 FEBRUARY, 2014

 

MUMBAI: Private equity giant Carlyle Group and Advent International are in discussions for a $150-million (Rs 900-crore) investment deal in Laurus Labs, a Hyderabad-based manufacturer of active pharmaceutical ingredients (APIs) for oncology and anti-retroviral drugs, at least two people familiar with the matter said.


The decade-old unlisted company, which also makes speciality ingredients for the nutraceutical industry, has attracted the interest of other private equity firms TA Associates and KKR as well. Investment bank Jefferies is running a fund-raising process for Laurus Labs.


The company — founded by pharma entrepreneur and former chief operating officer of Matrix Laboratories Dr Satyanarayana Chava, and arguably one of the fastest growing API makers — is said to be seeking a valuation of $450-500 million (Rs 28000.000-30.000,1000.000 Millions).

 

The investment deal could see existing investor Fidelity Growth Partners, which invested Rs 2000.000 Millions in FY12, part-selling some of its shares in the company. "The transaction may be a combination of fresh cash infusion and some secondary purchase of shares from existing investors," a person directly involved with the matter said.


The fund-raise has been opened up only to a select list of private equity investors, the person added, asking not to be named as the talks are private. Laurus Labs founder and CEO Satyanarayana Chava could not be reached despite repeated calls. An emailed query remained unanswered at the time of going to press.


Last year, Laurus Labs said it was setting up two more manufacturing plants besides the existing one in Visakhapatnam, and was also working on making APIs for diabetes drugs.



 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.12

UK Pound

1

Rs.102.00

Euro

1

Rs.81.43

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

SUB

 

 

Report Prepared by :

KVT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

51

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.